Clinical Trial Update: Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating selective lymph node dissection for early-stage invasive non-small cell lung cancer (cT1N0M0, CTR>0.5) in the apical segmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: Lung Adenocarcinoma, Lymph Node Metastasis | Phase 3 | Status: RECRUITING